Combinatorial Toll-like Receptor Agonists: Advancing Immune Modulation for Global Health Challenges

Toll-like receptors (TLRs) are essential pattern recognition receptors that initiate innate immune responses and shape adaptive immunity. While individual TLR agonists have been extensively used as vaccine adjuvants and immunomodulators, recent advancements highlight the potential of concurrently activating multiple TLRs to mimic natural infections and generate more effective synergistic immune responses. This review examines the molecular and cellular principles underlying multi-TLR activation, including receptor localization, signaling crosstalk, ligand affinity, and temporal dynamics. Additionally, the review explores recent strategies for delivering combinatorial TLR agonists along with their clinical implications. A deeper mechanistic understanding of combinatorial TLR engagement could pave the way for the rational design of next-generation adjuvants and personalized immunotherapies for infectious diseases, cancer, and beyond.